Indeed, transgenic mice expressing a C/Y-FRET-based AMPK biosensor show preferential activation of AMPK in skeletal muscle with the AMP analogs AICAR or in liver with metformin, the popular type 2 diabetes drug [159]. This evidence concerns the gene PRKAA2 and type 2 diabetes mellitus.